Skip to Content
Søg Menu
Vi dækker

ECCO | European
Crohn´s and Colitis Organisation

Seneste fra ECCO 2025

Arnaud Bourreille

New Mode of Action Provides New Treatment Options for IBD

/ Arnaud Bourreille
Colitis ulcerosaECCO25IBD Play the Video

Andreas Sturm

Mirikizumab Is Effective and Safe for Elderly Patients with Ulcerative Colitis

/ Andreas Sturm
Colitis ulcerosaECCO25IBD Play the Video
Mehdi Osooli

Reducing Opioid Use in Inflammatory Bowel Disease: A Critical Need

/ Mehdi Osooli
ECCO25IBD Play the Video
Peter Bossuyt

There Is a Lack of Data on the Effect of Dose Optimization

/ Peter Bossuyt
CrohnECCO25 Play the Video

ECCO 2019: Vedolizumab vs adalimumab in patients with active ulcerative colitis

/ Stefan Schreiber
ECCO19 Play the Video

ECCO 2019: App til måling af sygdomsaktivitet ved IBD og snart også IBS

/ Pia Munkholm
ECCO19 Play the Video

ECCO 2019: Serum biomarkers associated with disease activity in Crohn’s disease

/ Joachim Høg Mortensen
CrohnECCO19 Play the Video
Hent flere

ECCO 2024

Thea Wiken

Vedolizumab and Ustekinumab as Treatment for Patients with Ulcerative Colitis

/ Thea Helm Wiken
Colitis ulcerosaECCO24 Play the Video

Increased Incidence of Comorbid Diseases 10 Years Prior to IBD Diagnosis

/ Anthony C. Ebert
ECCO24IBD Play the Video
Gorm Roager Madsen

Periodontitis Seems to Be Linked to Increased IBD Disease Activity and Disability

/ Gorm Roager Madsen
ECCO24IBD Play the Video
Marc Ferrante

Mirikizumab As a Potential New Treatment in Patients with Crohn’s Disease

/ Marc Ferrante
CrohnECCO24 Play the Video
Daniele Noviello

Risankizumab Downregulates IL-23-Induced Mucosal Pathogenic Th17 Cells in Patients with Crohn’s Disease

/ Daniele Noviello
CrohnECCO24 Play the Video
Anja Poulsen

Colon Involvement or Isolated Small Intestinal Resection is Associated with a Higher Risk of Re-Resection in Crohn’s Disease Patients

/ Anja Poulsen
CrohnECCO24 Play the Video
Hent flere

ECCO 2023

The Increasing Burden of Direct and Indirect Costs of IBD – Looking for Potential Solutions

/ Jan Andreasen
ECCO23IBDSundhedsøkonomi
Liselotte Fierens

Can We Improve the Quality of Care in Inflammatory Bowel Disease?

/ Liselotte Fierens
ECCO23IBD Play the Video
Adam Faye

Antibiotic Exposure Increases the Risk of IBD Among Adults

/ Adam Faye
ECCO23IBD Play the Video
Johan Burisch

Main Points from the Lancet Commissioned IBD

/ Johan Burisch
ECCO23IBD Play the Video

Gastroenterologi & UEGW 2023 • Meet the experts

Get access
Øyvind Steinsbø

F-calprotectin associeret med mucosal inflammtorisk aktivitet ved colitis ulcerosa

/ Øyvind Steinsbø
Colitis ulcerosaECCO23IBD Play the Video
Linéa Bonfils

Increased Medication Use Prior to IBD Diagnosis

/ Linéa Bonfils
ECCO23IBD Play the Video
Manasi Agrawal

ICR versus Anti-TNF Therapy in Crohn’s Disease

/ Manasi Agrawal
CrohnECCO23 Play the Video
Gunnar Andreas Walaas

Physiological Hypoxia Improves Growth and Differentiation of Human Colonoids

/ Gunnar Andreas Walaas
ECCO23 Play the Video
Marie Villumsen

Significant Improvement in Physical Health and Mental Quality of Life for Patients with IBD

/ Marie Villumsen
ECCO23IBD Play the Video
Fredrik Bergenheim

The ECCO 2023 Intensive IBD Academy

/ Fredrik Bergenheim
ECCO23IBD Play the Video
Nathalie Fogh Rasmussen

Significantly Higher Risk of Surgery in Inflammatory Bowel Disease for Men

/ Nathalie Fogh Rasmussen
ECCO23IBD Play the Video

A New Potential Clinical Marker for Extraintestinal Manifestations in IBD

/ Ignacio Catalan-serra
ECCO23IBD Play the Video
Heidi Søgaard Christensen

No Altered Risk of IBD Associated with the Overall Use of GLP-1 Based Therapies

/ Heidi Søgaard Christensen
ECCO23IBD Play the Video
Hent flere

Mere fra ECCO

ECCO 2019: Elderly-onset IBD patients are less aggressively treated than younger patients

/ Natalia Pedersen
ECCO19 Play the Video

ECCO 2019: Transcriptional profiling of ulcerative colitis in remission

/ Ruth Paulssen
ECCO19 Play the Video

ECCO 2019: Treatment of IBD with thiopurine and allopurinol vs thiopurine monotherapy

/ Sandra Bohn Thomsen
ECCO19 Play the Video

ECCO 2019: Direct and indirect costs of IBD in the biological era

/ Bobby Zhao Sheng Lo
ECCO19 Play the Video

ECCO 2019: Bone mineral disease is insufficiently evaluated in patients with IBD

/ Bobby Zhao Sheng Lo
ECCO19 Play the Video

ECCO 2019: Vedolizumab vs anti-TNF in biologic-naive uc-patients

/ Andres Yarur
ECCO19 Play the Video

ECCO 2019: UC and CD increased the risk of Type 2 Diabetes

/ Marie Villumsen
ECCO19 Play the Video

ECCO 2019: Vedolizumab and anti-TNF in Crohn’s disease are equally effective

/ Brian Bressler
CrohnECCO19 Play the Video
Hent flere

Back to top